{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "P",
          "position": "42"
        },
        "variant_string_id": "PARK2 R42P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the parkin gene, which encodes a ubiquitin ligase, are currently recognized as the main contributor to familial forms of Parkinson's disease (PD).",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as related to the dysfunction of the parkin gene, which is involved in ubiquitination and protein degradation, leading to PD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "We have conducted a systematic analysis of a significant number of parkin point mutants (22 in total), which represent the majority of parkin missense/nonsense mutations reported to date.",
          "judgment": "Yes",
          "reasoning": "The study uses a systematic approach to analyze parkin mutants, which is applicable to understanding the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Our initial expression studies of the parkin point mutants in HEK 293 cells indicated that most of these mutants, except for A82E, M192L, K211N, T240R, T415N, G430D and P437L are expressed poorly relative to wild-type parkin.",
          "judgment": "Yes",
          "reasoning": "The study includes controls and replicates, as indicated by the comparison of mutant expressions to wild-type parkin.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "We found that more than half of these mutations, including many located outside of the parkin RING fingers, produce alteration in the solubility of parkin which influences its detergent extraction property.",
          "judgment": "Yes",
          "reasoning": "The study examines the effects of mutations on parkin solubility and aggregation, which are relevant to the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The parkin substrates CDCrel-1 and Synphilin-1 are not sequestered within the parkin-mutant mediated aggregates.",
          "judgment": "No",
          "reasoning": "The study does not provide statistical analyses sufficient to estimate or calculate OddsPath for the functional data.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "We have conducted an analysis of a large number of parkin point mutants (22 in total), which represent the majority of parkin missense/nonsense point mutations reported to date.",
          "judgment": "Yes",
          "reasoning": "The study includes a large number of variants, but does not specify the number of benign/pathogenic controls used.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The R42P variant in PARK2 is associated with altered solubility and aggregation properties, supporting its pathogenic role in PD, but the evidence strength is limited to supporting due to lack of statistical analyses and specific control details."
    }
  ]
}